Back

Novel drugs in heart failure: what's on the horizon?

21 May 2016 (08:30 - 08:45)
Organised by:
Congress Presentation Part of: Novel drugs - how do they work? Miscellaneous HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Christoph Maack

University Clinic Wuerzburg, Wuerzburg (Germany)

5 More presentations in this session

Presentation thumbnail
Effects of serelaxin on a systolic cardiac dysfunction induced by isoproterenol in mice with increased cardiac aldosterone
Doctor G. Billebeau (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Why treatment with natriuretic peptide analogs failed to fulfill our expectations? - receptor expression and function in a failing heart.
Doctor K. Kodziszewska (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
ORM-3819 promotes cardiac contractility on a dual mechanism of action: troponin-C dependent calcium sensitization is supported by selective PDE III inhibition
Doctor L. Nagy (Debrecen, HU)
Abstract
Presentation thumbnail
Vepoloxamer (purified poloxamer-188) improves LV function, limits cardiomyocyte calcium overload and restores integrity of calciu cycling proteins in myocardium of dogs with advanced heart failure
Professor H. Sabbah (Detroit, US)
Abstract Slides Video
Presentation thumbnail
Targeting HDACs in heart failure.

Access the full session

Session thumbnail
Novel drugs - how do they work?

The Event

Event poster

HEART FAILURE 2016

21 May 2016 08:30 CET
You may be interested in
thumbnail
Congress Session
Transforming heart failure care: unlocking new pathways
19 May 2025
thumbnail
Congress Presentation
Early reverse remodelling assessed by myocardial work after sacubitril-valsartan therapy
3 September 2019
thumbnail
Congress Presentation
A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)
26 August 2022
thumbnail
Congress Presentation
Prescription patterns of disease modyfing drugs of patients admitted to an advanced heart failure unit
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources